bristol-myers glp-1 receptor agonist products Repurposing glucagon-like peptide-1 agonists for the treatment of neurodegenerative disorders GLP-1 Receptor Agonists Reduce Adverse
Description
WangYParlevlietETGeerlingJJvan der TuinSJZhangHBieghsVet alExendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
4,5 TABLE 1 provides a summary of key characteristics of currently available injectable GLP-1 receptor agonists
But that's not all
Written informed consent was obtained from all patients
Sloop, K.W
